The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Open accessAbstract
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsing-remitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity (134, 139–143).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
In the citing paper
“Interestingly, even MS patients with active disease have an altered microbiota compared to patients in the remission phase, which in turn have a microbiota more similar to healthy controls (25, 134–138).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 810
Miyamoto, K., Sujino, T., Harada, Y., Ashida, H., Yoshimatsu, Y., Yonemoto, Y., Nemoto, Y., Tomura, M., Melhem, H., Niess, J. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113005 · Cited by 64
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 63
Sardarni, U. K., Shet, A., Rajnala, N., Gopalan, B. P., Moar, P., Himanshu, D., Singh, B. P., Chaturvedi, R., & Tandon, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35877-4 · Cited by 60
Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System
Colpitts, S. L., & Kasper, L. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601438 · Cited by 61
Yadav, S. K., Boppana, S., Ito, N., Mindur, J. E., Mathay, M., Patel, A. H., Dhib-Jalbut, S. S., & Ito, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615715114 · Cited by 62
Jørgensen, S. F., Fevang, B., & Aukrust, P. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0574-z · Cited by 61
Kusakabe, S., Fukushima, K., Maeda, T., Motooka, D., Nakamura, S., Fujita, J., Yokota, T., Shibayama, H., Oritani, K., & Kanakura, Y. (2019) · British Journal of Haematology · doi:10.1111/bjh.16205 · Cited by 62
Cady, N. M., Peterson, S. R., Freedman, S. N., & Mangalam, A. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00150 · Cited by 61
Autoimmunity and COVID-19 – The microbiotal connection
Katz-Agranov, N. S., & Zandman‐Goddard, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102865 · Cited by 64
Majo, D. D., Cacciabaudo, F., Accardi, G., Gambino, G., Giglia, G., Ferraro, G., Candore, G., & Sardo, P. (2022) · Nutrients · doi:10.3390/nu14122384 · Cited by 63
Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 61
Gong, J., Qiu, W., Zeng, Q., Liu, X., Sun, X., Li, H., Yang, Y., Wu, A., Bao, J., Wang, Y., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518790396 · Cited by 60
Prevotella Copri and Microbiota in Rheumatoid Arthritis: Fully Convincing Evidence?
Drago, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111837 · Cited by 60
The potential of outdoor environments to supply beneficial butyrate-producing bacteria to humans
Brame, J. E., Liddicoat, C., Abbott, C. A., & Breed, M. F. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146063 · Cited by 60
Plichta, D. R., Somani, J., Pichaud, M., Wallace, Z. S., Fernandes, A. D., Perugino, C. A., Lähdesmäki, H. J., Stone, J. H., Vlamakis, H. C., Chung, D. C., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00853-7 · Cited by 63
Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
Plassais, J., Gbikpi‐Benissan, G., Figarol, M., Scheperjans, F., Gorochov, G., Derkinderen, P., & Cervino, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab113 · Cited by 58
Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells
Calvo‐Barreiro, L., Zhang, L., Abdel‐Rahman, S. A., Naik, S. P., & Gabr, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021806 · Cited by 62
Western lifestyle and immunopathology of multiple sclerosis
Matveeva, O., Bogie, J. F. J., Hendriks, J. J. A., Linker, R. A., Haghikia, A., & Kleinewietfeld, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13583 · Cited by 65
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 60
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Zhu, F., Li, C., Chu, F., Tian, X., & Zhu, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.544235 · Cited by 59
Heravi, F. S. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00213-6 · Cited by 67
Tao, Y., Zhu, X., Wang, H., Wang, Y., Li, X., Jin, H., & Rui, J. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.07.036 · Cited by 58
Importance of the intestinal microbiota in ocular inflammatory diseases: A review
Lin, P. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13493 · Cited by 59
The impact of intermittent fasting on gut microbiota: a systematic review of human studies
Paukkonen, I., Törrönen, E.-N., Lok, J., Schwab, U., & El-Nezami, H. S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1342787 · Cited by 63
Rawat, K., Singh, N., Kumari, P., & Saha, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0078 · Cited by 61
The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis
Bărcuţean, L., Maier, S., Patrascu, M. B., Farczádi, L., & Bălașa, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063198 · Cited by 62
Reciprocal interactions between bile acids and gut microbiota in human liver diseases
Ikegami, T., & Honda, A. (2017) · Hepatology Research · doi:10.1111/hepr.13001 · Cited by 54
Impact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 54
Exploring the Gut Microbiome in Myasthenia Gravis
Thye, A. Y.-K., Law, J. W., Tan, L. T., Thurairajasingam, S., Chan, K., Letchumanan, V., & Lee, L. (2022) · Nutrients · doi:10.3390/nu14081647 · Cited by 61
Role of the intestinal microbiome in autoimmune diseases and its use in treatments
Marietta, E. V., Horwath, I. E., Balakrishnan, B., & Taneja, V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.005 · Cited by 55
Rosa, G. L., Lonardo, M. S., Cacciapuoti, N., Muscariello, E., Guida, B., Faraonio, R., Santillo, M., & Damiano, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087247 · Cited by 56
Stanisavljević, S., Lukić, J., Bajić, S. S., Mihajlović, S., Stojković, M. M., Miljković, D. M., & Golić, N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02005 · Cited by 55
Intestinal Microbes in Autoimmune and Inflammatory Disease
Wu, W.-J. H., Zegarra-Ruiz, D. F., & Diehl, G. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597966 · Cited by 54
The Application of Metabolomics to Probiotic and Prebiotic Interventions in Human Clinical Studies
O’Connell, T. M. (2020) · Metabolites · doi:10.3390/metabo10030120 · Cited by 57
Suskun, C., Kılıç, Ö., Çiftdoğan, D. Y., Güven, Ş., Karbuz, A., Parlakay, A. Ö., Kara, Y., Kaçmaz, E., Şahin, A., Boğa, A., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04494-9 · Cited by 54
Ma, Y., Sannino, D. R., Linden, J. R., Haigh, S. V., Zhao, B., Grigg, J. B., Zumbo, P., Dündar, F., Butler, D., Profaci, C. P., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163239 · Cited by 51
Chitrala, K. N., Guan, H., Singh, N. P., Busbee, P. B., Gandy, A. O., Mehrpouya‐Bahrami, P., Ganewatta, M. S., Tang, C., Chatterjee, S., Nagarkatti, P. S., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646792 · Cited by 56
Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China
Feng, W., Xu, H., Yan, C., Rong, C., Liu, B., & Zhou, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213063 · Cited by 52
Gut microbiome and multiple sclerosis: New insights and perspective
Amini, M. E., Shomali, N., Bakhshi, A., Rezaei, S., Hemmatzadeh, M., Hosseinzadeh, R., Eslami, S., Babaie, F., Aslani, S., Torkamandi, S., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107024 · Cited by 54
Jiang, J., Chu, C., Wu, C., Wang, C., Zhang, C., Li, T., Zhai, Q., Yu, L., Tian, F., & Chen, W. (2021) · Food & Function · doi:10.1039/d0fo03203d · Cited by 52
Storm-Larsen, C., Myhr, K.-M., Farbu, E., Midgard, R., Nyquist, K., Broch, L., Berg‐Hansen, P., Buneß, A., Holm, K., Ueland, T., et al. (2019) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319888767 · Cited by 51
Breaking down the gut microbiome composition in multiple sclerosis
Budhram, A., Parvathy, S., Kremenchutzky, M., & Silverman, M. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516682105 · Cited by 51
Bacterial variation in the oral microbiota in multiple sclerosis patients
Zangeneh, Z., Ali, A. A., Khamooshian, K., Alvandi, A., & Abiri, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260384 · Cited by 50
Gut microbiota: a new insight into neurological diseases
Liu, L., Wang, H., Chen, X., & Xie, P. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002212 · Cited by 52
Park, A.-M., Omura, S., Fujita, M., Sato, F., & Tsunoda, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12401 · Cited by 55
Ertürk-Hasdemir, D., Ochoa‐Repáraz, J., Kasper, D. L., & Kasper, L. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662807 · Cited by 51
Social-Stress-Responsive Microbiota Induces Stimulation of Self-Reactive Effector T Helper Cells
Werbner, M., Barsheshet, Y., Werbner, N., Zigdon, M., Averbuch, I., Oren, Z., Brant, B., Elliott, E., Gelberg, S., Titelbaum, M., et al. (2019) · mSystems · doi:10.1128/msystems.00292-18 · Cited by 49
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications
Wang, X., Liang, Z., Wang, S., Ma, D., Zhu, M., & Feng, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210629145351 · Cited by 49
Pellizoni, F. P., Leite, A. Z., Rodrigues, N. D. C., Ubaiz, M. J., Gonzaga, M. I., Takaoka, N. N. C., Mariano, V. S., Omori, W. P., Pinheiro, D. G., Matheucci, E., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094621 · Cited by 50
Dopkins, N., Miranda, K., Wilson, K. M., Holloman, B. L., Nagarkatti, P. S., & Nagarkatti, M. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10023-6 · Cited by 49
Jeffery, N. D., & Granger, N. P. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1114798 · Cited by 48
The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders
Dunalska, A., Saramak, K., & Szejko, N. (2023) · Cells · doi:10.3390/cells12131760 · Cited by 45
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 49
Montgomery, T. L., Wang, Q., Mirza, A., Dwyer, D., Wu, Q., Dowling, C. A., Martens, J. W. S., Yang, J., Krementsov, D. N., & Mao‐Draayer, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64369-x · Cited by 48
An expanding stage for commensal microbes in host immune regulation
Shi, Y., & Mu, L. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.64 · Cited by 46
A systematic review of gut‐immune‐brain mechanisms in Autism Spectrum Disorder
Azhari, A., Azizan, F., & Esposito, G. (2018) · Developmental Psychobiology · doi:10.1002/dev.21803 · Cited by 52
Shahi, S. K., Jensen, S. N., Murra, A. C., Tang, N., Guo, H., Gibson-Corley, K. N., Zhang, J., Karandikar, N. J., Murray, J. A., & Mangalam, A. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578648 · Cited by 47
A Review of the Role of the Intestinal Microbiota in Age-Related Macular Degeneration
Lin, P., McClintic, S. M., Nadeem, U., & Skondra, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102072 · Cited by 48
B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients
Troci, A., Zimmermann, O. L., Esser, D., Krampitz, P., May, S., Franke, A., Berg, D., Leypoldt, F., Stürner, K. H., & Bang, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-07336-8 · Cited by 48
Shahi, S. K., Ghimire, S., Lehman, P., & Mangalam, A. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966417 · Cited by 47
Carrillo-Salinas, F. J., Mestre, L., Mecha, M., Feliú, A., del Campo, R., Villarrubia, N., Espejo, C., Montalbán, X., Alvarez-Cermeño, J. C., Villar, L. M., et al. (2017) · Scientific Reports · doi:10.1038/srep44377 · Cited by 47
Mestre, L., Carrillo-Salinas, F. J., Mecha, M., Feliú, A., Espejo, C., Alvarez-Cermeño, J. C., Villar, L. M., & Guaza, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01374 · Cited by 48
Galluzzo, P., Capri, F. C., Vecchioni, L., Realmuto, S., Scalisi, L., Cottone, S., Nuzzo, D., & Alduina, R. (2021) · Life · doi:10.3390/life11070620 · Cited by 46
Hashemi, B., Abdollahi, M., Abbaspour‐Aghdam, S., Hazrati, A., Malekpour, K., Meshgi, S., Kafil, H. S., Ghazi, F., Yousefi, M., Roshangar, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114195 · Cited by 49
Feeding the gut microbiome: impact on multiple sclerosis
Bronzini, M., Maglione, A., Rosso, R., Matta, M., Masuzzo, F., Rolla, S., & Clerico, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176016 · Cited by 49
Update on the gut microbiome in health and diseases
Salvadori, M., & Rosso, G. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.89196 · Cited by 52
The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease
Mowry, E. M., & Glenn, J. D. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.08.008 · Cited by 48
Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice
Yamashita, M., Ukibe, K., Matsubara, Y., Hosoya, T., Sakai, F., Kon, S., Arima, Y., Murakami, M., Nakagawa, H., & Miyazaki, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02596 · Cited by 45
Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?
Strzępa, A., Lobo, F. M., Majewska‐Szczepanik, M., & Szczepanik, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.021 · Cited by 46
Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
Liu, M.-T., Huang, Y., Zhang, T., Tan, L., Lu, X., & Qin, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i27.3590 · Cited by 45
Fleck, A.-K., Schuppan, D., Wiendl, H., & Klotz, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071526 · Cited by 47
Gut Microbiota and Neurologic Diseases and Injuries
Patterson, T. T., & Grandhi, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_6 · Cited by 46
Blais, L. L., Montgomery, T. L., Amiel, E., Deming, P. B., & Krementsov, D. N. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1943289 · Cited by 45
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
Kazemifard, N., Dehkohneh, A., & Ghavami, S. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.940454 · Cited by 48
Stanisavljević, S., Čepić, A., Bojić, S., Veljović, K., Mihajlović, S., Đedović, N., Jevtić, B., Momčilović, M., Lazarević, M., Mostarica Stojković, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37505-7 · Cited by 43
Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health
Cocean, A.-M., & Vodnar, D. C. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111073 · Cited by 52
Modification of the gut microbiome to combat neurodegeneration
Sasmita, A. O. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0005 · Cited by 50
Volkova, A., & Ruggles, K. V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.621310 · Cited by 45
Calvo‐Barreiro, L., Eixarch, H., Cornejo, T., Costa, C., Castillo, M., Mestre, L., Guaza, C., Martínez‐Cuesta, M. C., Tanoue, T., Honda, K., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01016-7 · Cited by 45
Mestre, L., Carrillo-Salinas, F. J., Mecha, M., Feliú, A., & Guaza, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.037 · Cited by 43
Fan, Y., & Zhang, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00740 · Cited by 42
The sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou‐El‐Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 44
Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?
van Laar, T., Boertien, J. M., & Herranz, A. H. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191802 · Cited by 43
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature
Russo, C. D., Scott, K. A., & Pirmohamed, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107710 · Cited by 45
Yadav, S. K., Ito, K., & Dhib-Jalbut, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914756 · Cited by 44
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
Kujawa, D., Łaczmański, Ł., Budrewicz, S. P., Pokryszko‐Dragan, A., & Podbielska, M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2274126 · Cited by 45
Gut microbial factors predict disease severity in a mouse model of multiple sclerosis
Steimle, A., Neumann, M., Grant, E. T., Willième, S., Sciscio, A. D., Parrish, A., Ollert, M. W., Miyauchi, E., Soga, T., Fukuda, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01761-3 · Cited by 48
Olejnik, P., Roszkowska, Z., Adamus, S., & Kasarełło, K. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00642-0 · Cited by 49
Role of diet in regulating the gut microbiota and multiple sclerosis
Sanchez, J. M. S., DePaula-Silva, A. B., Libbey, J. E., & Fujinami, R. S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108379 · Cited by 42
Mestre, L., Carrillo-Salinas, F. J., Feliú, A., Mecha, M., Alonso, G., Espejo, C., Calvo‐Barreiro, L., Luque-Garcia, J. L., Estévez, H., Villar, L. M., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1813532 · Cited by 42
Kishikawa, T., Ogawa, K., Motooka, D., Hosokawa, A., Kinoshita, M., Ken, S., Yamamoto, K., Masuda, T., Matsumoto, Y., Nii, T., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.585973 · Cited by 41
Denny, J. E., Powell, W. L., & Schmidt, N. W. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00041 · Cited by 41
A study of dietary modification: Perceptions and attitudes of patients with multiple sclerosis
Brenton, J. N., & Goldman, M. D. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.04.009 · Cited by 40
Jeffery, N. D., Barker, A. K., Alcott, C. J., Levine, J. M., Meren, I. L., Wengert, J. A., Jergens, A. E., & Suchodolski, J. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170589 · Cited by 40
Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty
Baptista, L. C. P., Sun, Y., Carter, C. S., & Buford, T. W. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00017 · Cited by 46
Yadav, S. K., Ito, N., Mindur, J. E., Kumar, H., Youssef, M., Suresh, S., Kulkarni, R., Rosario, Y., Balashov, K. E., Dhib-Jalbut, S. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1015372 · Cited by 41
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 48
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 48
Libbey, J. E., Sanchez, J. M. S., Doty, D. J., Sim, J. T., Cusick, M. F., Cox, J. E., Fischer, K. F., Round, J. L., & Fujinami, R. S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0116 · Cited by 40
Chiu, L. S., & Anderton, R. S. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15892 · Cited by 36
Metadata
- Authors
- Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M., & Yamamura, T.
- Affiliations
- Juntendo University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- The University of Tokyo (JP)
- National Institute of Neuroscience (JP)
- Azabu University (JP)
- Corresponding author
- Hattori, Masahira
- Yamamura, Takashi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-14
- Volume
- 10
- Issue
- 9
- Pages
- e0137429
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4569432
- OpenAlex
- W2200372542
- Cited by
- 809
- References
- 41
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 83 · 2023: 68 · 2022: 91 · 2021: 89 · 2020: 89 · 2019: 76 · 2018: 85 · 2017: 76 · 2016: 38 · 2015: 2
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Health, Labour and Welfare
- University of Tokyo
- Japan Society for the Promotion of Science (24229006, 26293234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- multiple sclerosis, gut microbiota, dysbiosis, Clostridium XIVa, Bacteroidetes, relapsing-remitting multiple sclerosis, experimental autoimmune encephalomyelitis, regulatory T cells, autoimmunity, 16S rRNA gene sequencing, fecal microbiota
- MeSH terms
- Gastrointestinal Microbiome, Adult, Clostridium, Female, Humans, Japan, Male, Multiple Sclerosis, RNA, Bacterial, RNA, Ribosomal, 16S, Sequence Analysis, RNA, Bacteroidetes, High-Throughput Nucleotide Sequencing, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
